Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection
- 1 May 1998
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 186 (1) , 18-27
- https://doi.org/10.1006/cimm.1998.1283
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Normal B cells fail to secrete interleukin‐12European Journal of Immunology, 1997
- The influence of virus structure on antibody responses and virus serotype formationImmunology Today, 1996
- Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59Vaccine, 1995
- Understanding the dendritic cell lineage through a study of cytokine receptors.The Journal of Experimental Medicine, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisitedImmunology Today, 1993
- Adjuvants: current status, clinical perspectives and future prospectsImmunology Today, 1993
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992
- Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.The Journal of Experimental Medicine, 1987
- Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody.The Journal of Experimental Medicine, 1986